Clinical Trial Update: Rituximab Trial for Pediatric Nephrotic Syndrome [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating rituximab for pediatric nephrotic syndrome (steroid-resistant and steroid-dependent) with current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Steroid-dependent Nephrotic Syndrome
• Steroid-resistant Nephrotic Syndrome

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Seoul National University Childrens Hospital | Conditions: Steroid Resistant Nephrotic Syndrome, Steroid Dependent Nephrotic Syndrome | Phase 2, Phase 3 | Status: UNKNOWN